# Trump may be mystery patient in odd case of 79yo getting experimental obesity drug

> **Newsylist Open Intelligence Dossier** · First detected: 2026-06-23 15:05 UTC · Category: Business · Sources: 5 · Current Velocity: 13.98

## Executive Summary
Speculation is mounting over whether Donald Trump was the mystery 79-year-old patient who received an experimental weight loss drug.

## Intelligence Brief
Reports have emerged regarding a 79-year-old patient who received special access to the experimental obesity drug Retatrutide. This has led to questions about whether Donald Trump was the individual in question, particularly following previous comments where he suggested he "probably should" take Ozempic.


Coverage from The Daily Beast and Ars Technica highlights the unusual nature of the case, while Mother Jones specifically questions if Trump received special access to the drug. However, Forbes reports that the White House has denied that Trump was given the exclusive weight loss medication.


Future developments depend on whether the identity of the patient is officially confirmed or if further evidence regarding the administration of the drug surfaces.

## Verified Facts & Key Claims
### What is the name of the experimental drug mentioned?
The drug is identified as Retatrutide.

### How has the White House responded to these claims?
According to Forbes, the White House has denied that Trump was given the exclusive weight loss drug.

### What is the age of the mystery patient?
The patient is 79 years old.

## Key People, Organizations & Locations
Trump, White House Cornered, Identity of Patient, Given Special Weight Loss Drug, Did Trump Get Special Access, Retatrutide, White House Denies Trump Was Given Exclusive Weight Loss Drug, Remember That Time Trump Said He

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| The Daily Beast | White House Cornered on Identity of Patient, 79, Given Special Weight Loss Drug | 2026-06-23 16:16 | [Source Link](https://news.google.com/rss/articles/CBMiwwFBVV95cUxPOXVpNy1fcTNoMWZpR0VVRjVQTXZ3UjVLTVhVZm9BQzJfSV9kaWV3bXRTVksxcFNsSVZtR3NBV040d0ZxT1hTV3JreW82UndwS0FaaE5qRURkQWZjVFpuaUZoN051Vjl3b01YSWNrRWVLYnF2Y0dvUF9PTUNQdnJKVEw2MkJfNHlGOEpxTl9uQ0xFZzVLT2dubHMzNnhRNlZDRFdlQTBNTEh4WVRadWpqWlZNOUJoUkhxVl91bjJtVk9lSkU?oc=5) |
| Mother Jones | Did Trump Get Special Access to Retatrutide? | 2026-06-23 16:16 | [Source Link](https://news.google.com/rss/articles/CBMifkFVX3lxTE9DcFlNeXF0RGt3c1NoanpQa19UOGM0MFRXOTkxV2p1Mkktcnh2N2hoRnNBa0o5Mjg0bHEyZk4yb2h0U2VkQUEzVXlJM2J5YUYzTjRyM0Z3b1E2SGRYNlEyOGl4SUlfdFJPSzBfUV9rYlhIbm1SaFNEakwyR1N5dw?oc=5) |
| Forbes | White House Denies Trump Was Given Exclusive Weight Loss Drug | 2026-06-23 16:16 | [Source Link](https://news.google.com/rss/articles/CBMi1AFBVV95cUxQUDlPUTFLRGQtQVlJdm5tWlpnMldsT3NNVHZHMVdJeFMwQWF1eENfR1BFWG9xV1pCR3ItSy1TZmlyandYX1pIb29XWHNucUYzRUdSRHBjd1JOeERyc1ByQ2NLNjBaNmJOUDdUYU9qbkVIQzZrZHotY2ZBYnJxd0I4ZXd1UzVVdm9XRGdRSkdLdV92YUFlREdNekpFSUJEYnBfMklMOXdTdUhPcERWNGZsblo5N0pLZDdkVmp0NXJjRkhwckF3WlhoZUlLOFlVMjFLNHN5SQ?oc=5) |
| The New Republic | Remember That Time Trump Said He “Probably Should” Take Ozempic? | 2026-06-23 16:16 | [Source Link](https://news.google.com/rss/articles/CBMiiAFBVV95cUxPUFh0ZVdBQ1ZKSGowb2Eyb2FCQngwMFRQQ2d1aXlaa0p0cXFrdnJvTWhISDdfUEJ0eVBDRXJfRW0zTS11T0NDZDd4WW5JMlBpYVdGYVVya3hrTGFCV25HNVRRT2dNWkF1anhRel9ROUNRaGd5c3B6MjZ2ZWdXNEc2V1c1TVZMU0cw?oc=5) |
| Ars Technica | Trump may be mystery patient in odd case of 79yo getting experimental obesity drug | 2026-06-23 16:16 | [Source Link](https://news.google.com/rss/articles/CBMivwFBVV95cUxOTERWUGpEekt5a0oyc295aTNoYU5leGQxejRvekJ3RDBXbnlFMy14S3F1bmFRdVc0ZUpxT1UzelgwZnhkajRwZDVaWGJTN3VQNWFBY1ZIbENJRnEtdzE5SklxWTB3Q0N2d21NYzZYU1Aya25lQlM5LTdNcGFNM0RaWFlnenRuRmVTNnl1NUZzVUVtclpJZFFuX2ZQTGc4c2pPWk5uZWw1ekxGZ0NlVXhMcWkydTliTzhKVE5GRXFTWQ?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-06-23/trump-may-be-mystery-patient-in-odd-case-of-79yo-getting-experimental-obesity*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*